The evolution of type 2 diabetes management: glycemic control and beyond with SGLT-2 inhibitors and GLP-1 receptor agonists.
第2型糖尿病管理的演變:使用SGLT-2抑制劑和GLP-1受體激動劑進行血糖控制及更多。
J Osteopath Med 2024-02-26
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes-Beyond and within GLP-1 Receptor Agonists.
肥胖症和第二型糖尿病藥物治療的新發展 - GLP-1 受體激動劑的範疇內和範疇外。
Biomedicines 2024-06-27
Novel Therapeutics for Type 2 Diabetes Mellitus-A Look at the Past Decade and a Glimpse into the Future.
2型糖尿病的新療法 - 回顧過去十年並展望未來。
Biomedicines 2024-07-27
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology.
GLP-1、DPP-4 和 SGLT2 在心血管、腎臟和代謝病理生理交匯處的角色洞察。
Cells 2025-03-12